Imaging techniques ordinarily used by eye doctors to monitor the optic nerve could offer a non-invasive method of measuring and managing potentially dangerous swelling in the skull, a new UK study has found.
The College of Medical and Dental Sciences has achieved the Athena SWAN Silver award from the Athena SWAN Foundation, recognising the College's commitment to gender equality.
Researchers based at the University of Birmingham are starting a ground-breaking maternal health trial across 80 hospitals in South Africa, Kenya, Nigeria, Tanzania and Sri Lanka.
Global health professionals are joining the latest in a series of online expert workshops aimed at improving the care of pregnant women during the current COVID-19 pandemic, particularly in low income countries
Using a simple urine test alongside routine imaging for patients with adrenal masses could speed up adrenal cancer diagnosis, according to a new UK study.
Health professionals around the globe can join a series of online expert workshops aimed at improving the care of pregnant women during the current COVID-19 pandemic, particularly in low- and middle-countries.
The University of Birmingham's spinout company Neuronostics has received funding to develop its BioEP platform, an AI-based system for faster, more accurate diagnosis of epilepsy and to monitor response to treatment.
Professor Davide Calebiro was presented the award following his lecture at the e-ECE 2020 virtual conference on 5th September 2020, in recognition of his contribution to scientific research in endocrine diseases.
Pregnant women hospitalised with COVID-19 are less likely to manifest common virus symptoms and may be at an increased risk of intensive care admission, a new study into the impacts of COVID-19 on pregnancy has found.
A new drug combination is more effective for women having miscarriages without symptoms than current standard NHS treatment, according to an NIHR funded study from Tommy's National Centre for Miscarriage Research.